期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

无保护左主干病变:PCI还是CABG?——PCI证据尚需积累,内外科合作是关键 被引量：1

下载PDF
导出
摘要 冠状动脉旁路移植术（CABG）由于能显著改善上述患者的生存率、提高生活质量而一直是无保护左主干病变（UPLM）的首选治疗手段[1]。但CABG也存在创伤较大、对患者一般情况要求较高等限制。而经皮冠状动脉介入治疗（PCI）,通过穿刺股动脉或桡动脉等方法将导管、导丝、球囊及支架等相关器械沿动脉送至冠状动脉相应的狭窄部位,解除冠状动脉狭窄,
作者 陈晖 沈潞华
机构地区 首都医科大学附属北京友谊医院心血管中心
出处 《山东医药》 CAS 2012年第4期4-5,共2页 Shandong Medical Journal
关键词 无保护左主干病变 经皮冠状动脉介入治疗 冠状动脉旁路移植术
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献1

二级参考文献70

  • 1Park DW;Park SW;Park KH.Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up,2006(03).
  • 2Seung KB,Park DW,Kim YH,et al.Stents versus coronary-artery bypass grafting for left main coronary artery disease. The New England Journal of Medicine . 2008
  • 3Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Journal of the American Medical Association, The . 2005
  • 4Stone GW,Moses JW,Ellis SG,Schofer J,Dawkins KD,Morice MC,Colombo A,Schampaert E,Grube E,Kirtane AJ,Cutlip DE,Fahy M,Pocock SJ,Mehran R,Leon MB.Safety and efficacy of sirolimus-and paclitaxel-eluting coro- nary stents. The New England Journal of Medicine . 2007
  • 5Serruys PW,Morice MC,Kappetein AP,Colombo A,Hol- mes DR,Mack MJ,St-hle E,Feldman TE,van den Brand M,Bass EJ,Van Dyck N,Leadley K,Dawkins KD,Mohr FW.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. The New England Journal of Medicine . 2009
  • 6Lagerqvist B,James SK,Stenestrand U,et al.Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. New England Journal of Medicine, The . 2007
  • 7Pijls NHJ,Van Gelder B,Van der Voort P,et al.Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation . 1995
  • 8Valgimigli M,Malagutti P,Aoki J,Garcia-Garcia HM,Ro- driguez Granillo GA,van Mieghem CA,Ligthart JM,Ong AT,Sianos G,Regar E,Van Domburg RT,De Feyter P,de Jaegere P,Serruys PW.Sirolimus-eluting versus paclitaxel- eluting stent implantation for the percutaneous treatment of left main coronary artery disease:a combined RESEARCH and T-SEARCH long-term analysis. Journal of the American College of Cardiology . 2006
  • 9Chaitman BR,Fisher LD,Bourassa MG,Davis K,Rog- ers WJ,Maynard C,Tyras DH,Berger RL,Judkins MP,Ringqvist I,Mock MB,Killip T.Effect of coronary bypass surgery on survival patterns in subsets of patients with leftmain coronary artery disease.Report of the Collaborative Study in Coronary Artery Surgery (CASS). The American Journal of Cardiology . 1981
  • 10Chieffo A,Stankovic G,Bonizzoni E,Tsagalou E,Iakovou I,Montorfano M,Airoldi F,Michev I,Sangiorgi MG,Carlino M,Vitrella G,Colombo A.Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation . 2005

共引文献12

同被引文献14

  • 1Morice MC, Serruys PW, Sousa JE, et al. A randomized compari-son of a sirolimus-eluting stent with a standard stent for coronary re- vascularization[ J]. N Engl J Med, 2002,246 (23) : 1773-1780.
  • 2Moes JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents ver- sus standard stents in patients with stenosis in a native coronary ar- tery[J]. N Engl J Med, 2003,349(7) :1315-1323.
  • 3Park SJ, Kim YH, Lee BK, et al. Sirolimous-eluting stent implan- tation for unprotected left main coronary atery senosis comparison with bare metal stent implantation[J]. J Am Coil Cardiol, 2005, 45(3) :351-356.
  • 4Takagi T, Tankovic G, Finci, et al. Results and long-term predic- tors of adverse clinical events after elective percutaneous interven- tions on unprotected left main coronary artery [ J ]. Circulation, 2002,106(20) :698-702.
  • 5Valglmigli M, Van Mieghem CA, Ong AT, et al. Short and hong- term clinical outcom after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease [ J ]. Circulation, 2005,111 ( 11 ) : 1383-1389.
  • 6Parks SJ, Kim YH. Current status of percutaneous coronary inter- vention with drug-eluting stents in Asia [ J ]. Circulation, 2008, 110(20) :2730-2737.
  • 7Holmes DR, Choi JW, Ruzyllo W, et al. Five-year outcomes in patients with left main disease treated with either pereutaneous cor- onary intervention or coronary artery bypass grafting in the SYN- TAX Trial[J]. Circulation, 2014,114(3 ) :3745-3748.
  • 8Lelasi A, Latib A, Chieffo A, et al. Very long-term outcomes fol- lowing drug-eluting stent implantation for unprotected left main cor- onary artery stenosis : a single center experience[J]. Rev Esp Car- diol ( Engl Ed), 2013,66( 1 ) :24-33.
  • 9Deb S, Wijeysundera HC, Ko DT, et al. Coronary artery bypass graft surgery vs pereutaneous interventions in coronary revascular- ization : a systematic review [ J ]. JAMA, 2013,310 ( 19 ) : 2086- 2095.
  • 10Sun J, Marx SO, Chen HJ, et al. Role for p27(Kipl)in vascular smooth muscle cell migration [ J ]. Circulation, 2001,103 ( 24 ) : 2967 -2972.

引证文献1

二级引证文献2

山东医药
2012年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部